Feminizing Adrenocortical Carcinoma with Distant Metastases: Can Surgery be Considered?
- PMID: 25332762
- PMCID: PMC4202184
- DOI: 10.4081/cp.2014.651
Feminizing Adrenocortical Carcinoma with Distant Metastases: Can Surgery be Considered?
Abstract
Functioning adrenocortical carcinomas are rare diseases with dismal prognosis. A 41-year-old man presenting with gynecomastia had a giant feminizing adrenocortical carcinoma at stage IV. Although surgical resection was controversial, we removed the primary tumor to reduce the mass effects. He lived for 12 months with an acceptable quality of life. Gynecomastia may be the first sign of feminizing adrenal malignancies. Surgery may ameliorate the quality of life in selected patients with metastatic disease.
Keywords: Adrenocortical carcinoma; feminizing; gynecomastia; rare tumor; treatment.
Conflict of interest statement
Conflicts of interest: the authors declare no potential conflicts of interest.
Figures



References
-
- Kidd MT, Karlin NJ, Cook CB. Feminizing adrenal neoplasms: case presentations and review of the literature. J Clin Oncol 2011;29:e127-30 - PubMed
-
- Lafemina J, Brennan MF. Adrenocortical carcinoma: past, present, and future. J Surg Oncol 2012;106:586-94 - PubMed
-
- Patalano A, Brancato V, Mantero F. Adrenocortical cancer treatment. Horm Res 2009;71:99-104 - PubMed
-
- Advani A, Johnson SJ, Nicol MR, Papacleovoulou G, et al. . Adult-onset hypogonadotropic hypogonadism caused by aberrant expression of aromatase in an adrenocortical adenocarcinoma. Endocr J 2010;57:651-6 - PubMed